ARPITA PATEL: Open Payments
NPI 1780084111 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$84 in 5 payments from 3 companies in 2025. Trend: 2023 $409 · 2024 $297 · 2025 $84
Food & beverage: $84
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $51 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $15 |
Products named: GEMTESA, FUROSCIX, ISTURISA.
Industry payments across NJ — which companies pay providers there.
